Association between psoriasis and coronary calcium score

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSTANIAK, Henrique L.
dc.contributor.authorBITTENCOURT, Marcio Sommer
dc.contributor.authorSANTOS, Itamar de Souza
dc.contributor.authorSHAROVSKY, Rodolfo
dc.contributor.authorSABBAG, Cid
dc.contributor.authorGOULART, Alessandra C.
dc.contributor.authorLOTUFO, Paulo A.
dc.contributor.authorBENSENOR, Isabela M.
dc.date.accessioned2015-04-22T22:06:26Z
dc.date.available2015-04-22T22:06:26Z
dc.date.issued2014
dc.description.abstractBackground: Emerging data suggests that chronic inflammatory disease, such as psoriasis, may be associated to coronary artery disease (CAD). Objective: Analyze the association between psoriasis and subclinical atherosclerosis using coronary calcium score (CAC). Methods: We investigated 221 participants with psoriasis and 718 age-and sex-matched controls without prior known CAD. All participants completed a questionnaire and underwent laboratory tests and a CAC exam. Logistic regression models adjusted for Framingham risk score (FRS) and C-reactive protein (hs-CRP) were built. CAC was included in the models as a binary variable with different cut off values. Results: Body-mass index, race, hypertension, HDL, LDL and hs-CRP were significantly associated with psoriasis presence and severity. Psoriasis severity was significantly associated with CAC (p = 0.04), particularly for very high CAC (>400) (p <0.01). The OR for severe psoriasis and CAC >400 was 2.45 (95%CI: 1.26-4.75) in unadjusted models. In a model adjusted for the FRS, this association was no longer significant, but a trend was noted (p = 0.09). No significant changes in the association were noted after the inclusion of hs-CRP in the model. Conclusion: Psoriasis is associated with higher CAC values, mainly in individuals with severe psoriasis. The current findings also suggest the potential involvement of other mechanisms beyond classical cardiovascular risk factors and inflammation in this association.
dc.description.indexMEDLINE
dc.description.sponsorshipCNPq
dc.description.sponsorshipFundacao para Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil [2011/7601-4, 2011/12256-4]
dc.description.sponsorshipBrazilian Ministry of Health (Science and Technology Department), Brasilia, Brazil [FINEP: 06 0115.00 SP]
dc.identifier.citationATHEROSCLEROSIS, v.237, n.2, p.847-852, 2014
dc.identifier.doi10.1016/j.atherosclerosis.2014.11.004
dc.identifier.eissn1879-1484
dc.identifier.issn0021-9150
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/8916
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofAtherosclerosis
dc.rightsrestrictedAccess
dc.rights.holderCopyright ELSEVIER IRELAND LTD
dc.subjectCoronary artery calcium
dc.subjectCardiovascular disease
dc.subjectCardiovascular risk factors
dc.subjectPsoriasis
dc.subjectSubclinical atherosclerosis
dc.subject.othersubclinical atherosclerosis
dc.subject.otherartery-disease
dc.subject.otherrisk-factors
dc.subject.otherarthritis
dc.subject.otherprevalence
dc.subject.otherhealth
dc.subject.wosPeripheral Vascular Disease
dc.titleAssociation between psoriasis and coronary calcium score
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalSHAROVSKY, Rodolfo:Univ Sao Paulo, Univ Hosp, Div Internal Med, BR-05508 Sao Paulo, Brazil; Univ Sao Paulo, Univ Hosp, Ctr Clin & Epidemiol Res, BR-05508 Sao Paulo, Brazil
hcfmusp.citation.scopus39
hcfmusp.contributor.author-fmusphcHENRIQUE LANE STANIAK
hcfmusp.contributor.author-fmusphcMARCIO SOMMER BITTENCOURT
hcfmusp.contributor.author-fmusphcITAMAR DE SOUZA SANTOS
hcfmusp.contributor.author-fmusphcCID YAZIGI SABBAG
hcfmusp.contributor.author-fmusphcALESSANDRA CARVALHO GOULART
hcfmusp.contributor.author-fmusphcPAULO ANDRADE LOTUFO
hcfmusp.contributor.author-fmusphcISABELA JUDITH MARTINS BENSEñOR
hcfmusp.description.beginpage847
hcfmusp.description.endpage852
hcfmusp.description.issue2
hcfmusp.description.volume237
hcfmusp.origemWOS
hcfmusp.origem.pubmed25463132
hcfmusp.origem.scopus2-s2.0-84911123142
hcfmusp.origem.wosWOS:000346066600101
hcfmusp.publisher.cityCLARE
hcfmusp.publisher.countryIRELAND
hcfmusp.relation.referenceAGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827
hcfmusp.relation.referenceAntonucci V.A., 2012, J EUR ACAD DERMATOL, V28, P512
hcfmusp.relation.referenceAquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
hcfmusp.relation.referenceArmstrong AW, 2012, AM J CARDIOL, V109, P976, DOI 10.1016/j.amjcard.2011.11.025
hcfmusp.relation.referenceArmstrong AW, 2013, J HYPERTENS, V31, P433, DOI 10.1097/HJH.0b013e32835bcce1
hcfmusp.relation.referenceAtzeni F, 2011, J RHEUMATOL, V38, P1661, DOI 10.3899/jrheum.100893
hcfmusp.relation.referenceBalci D.D., 2009, EUR ACAD DERMATOL VE, V23, P1
hcfmusp.relation.referenceCoto-Segura P., 2013, BR J DERMATOL, V91
hcfmusp.relation.referenceDowlatshahi EA, 2013, J INVEST DERMATOL, V133, P2347, DOI 10.1038/jid.2013.131
hcfmusp.relation.referenceDowlatshahi E.A., 2013, BR J DERMATOL, V168
hcfmusp.relation.referenceEder L., 2013, ANN RHEUM DIS, V73, P1990
hcfmusp.relation.referenceEder L, 2008, J RHEUMATOL, V35, P877
hcfmusp.relation.referenceEnany B., 2012, HERZ, V5, P527
hcfmusp.relation.referenceFinlay AY, 2005, BRIT J DERMATOL, V152, P861, DOI 10.1111/j.1365-2133.2005.06502.x
hcfmusp.relation.referenceGaeta M., 2013, INT J CARDIOL
hcfmusp.relation.referenceGelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537
hcfmusp.relation.referenceGelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735
hcfmusp.relation.referenceGonzalez-Juanatey C, 2007, ARTHRIT RHEUM-ARTHR, V57, P1074, DOI 10.1002/art.22884
hcfmusp.relation.referenceKaul M.S., 2012, ARTHRIT CARE RES, V65, P266
hcfmusp.relation.referenceKimhi O., 2007, ARTHRITIS RHEUM, V36, P203
hcfmusp.relation.referenceKurd SK, 2009, J AM ACAD DERMATOL, V60, P218, DOI 10.1016/j.jaad.2008.09.022
hcfmusp.relation.referenceLudwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x
hcfmusp.relation.referenceMehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567
hcfmusp.relation.referencePatel RV, 2011, J GEN INTERN MED, V26, P1036, DOI 10.1007/s11606-011-1698-5
hcfmusp.relation.referencePitzalis C, 1998, BRIT J RHEUMATOL, V37, P480
hcfmusp.relation.referenceTam LS, 2008, ARTHRIT RHEUM-ARTHR, V59, P1322, DOI 10.1002/art.24014
hcfmusp.relation.referenceThe Centers for Disease Control and Prevention, 2004, NAT HLTH NUTR EX SUR
hcfmusp.relation.referenceTroitzsch P, 2012, ATHEROSCLEROSIS, V225, P486, DOI 10.1016/j.atherosclerosis.2012.09.026
hcfmusp.relation.referenceWarrington KJ, 2005, ARTHRITIS RES THER, V7, pR984, DOI 10.1186/ar1775
hcfmusp.relation.referenceWilson PWF, 1998, CIRCULATION, V97, P1837
hcfmusp.relation.referenceYiu KH, 2013, J INTERN MED, V273, P273, DOI 10.1111/joim.12002
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication89157b04-1b82-4f40-8fcb-ed090079a864
relation.isAuthorOfPublicatione3193e19-6ede-49dd-bde8-98da34ff70d1
relation.isAuthorOfPublicatione566281f-a9d6-4882-b281-5031a0141a11
relation.isAuthorOfPublicatione424494a-256a-4ccf-9d32-61f66721c3cc
relation.isAuthorOfPublicationcd675f04-b4ad-47f1-8d3c-15f6cb73d8cf
relation.isAuthorOfPublicationcb0c8dbb-6df5-4294-8d8e-e96645a3cec1
relation.isAuthorOfPublication6911f59e-7ec9-4ad2-b746-580bf8b3d64d
relation.isAuthorOfPublication.latestForDiscovery89157b04-1b82-4f40-8fcb-ed090079a864
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_STANIAK_Association_between_psoriasis_and_coronary_calcium_score_2014.PDF
Tamanho:
691.34 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)